Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Award Notice

Supply and Maintnenance of Cord Blood Cell Separation System

  • First published: 07 April 2018
  • Last modified: 07 April 2018
  • Version: N/A
  •  

  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
Published by:
NHS Blood & Transplant
Authority ID:
AA20525
Publication date:
07 April 2018
Deadline date:
-
Notice type:
Contract Award Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

1.1. Cord Blood Bank (CBB) forms part of the Specialist Services Directorate of NHSBT. The CBB laboratory provides services to support haematopoietic stem cell transplantation including collection, processing and cryopreservation of cord blood derived stem cells.

1.2. Cord blood is rich in blood stem cells, similar to those found in bone marrow, and these can be used to treat many different cancers, immune deficiencies and genetic disorders. For the transplant to be a success, stem cells taken from the cord blood must match the patient's tissue type as closely as possible.

1.3. The recent report from the UK Stem Cell Strategic Forum sets out a strategy to save an additional 200 lives year by increasing the number of umbilical cord blood units banked in the UK. NHSBT currently banks ~2300 units/annum and will continue to do so until an optimal bank size of 30 000 has been reached by 2020. After which banking will continue at a reduced rate.

1.4. The NHS CBB has been performing plasma and red cell depletion of cord blood prior to cryopreservation since 1997 and has utilised a fully automated centrifugation based processing platform since 2003 and requires a functionally closed, sterile, automated separation system.

Full notice text

Contract award notice

Results of the procurement procedure

Section I: Contracting authority

I.1) Name and addresses

NHS Blood and Transplant

North Bristol Park

Filton, Bristol

BS34 7QH

UK

Telephone: +44 1179217241

E-mail: marnie.watkins@nhsbt.nhs.uk

NUTS: UK

Internet address(es)

Main address: www.blood.co.uk

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Supply and Maintnenance of Cord Blood Cell Separation System

Reference number: NHSBT0982

II.1.2) Main CPV code

33100000

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

Supply and Maintnenance of Cord Blood Cell Separation System.

II.1.6) Information about lots

This contract is divided into lots: No

II.1.7) Total value of the procurement

Value excluding VAT: 283 470.00  GBP

II.2) Description

II.2.3) Place of performance

NUTS code:

UK

II.2.4) Description of the procurement

1.1. Cord Blood Bank (CBB) forms part of the Specialist Services Directorate of NHSBT. The CBB laboratory provides services to support haematopoietic stem cell transplantation including collection, processing and cryopreservation of cord blood derived stem cells.

1.2. Cord blood is rich in blood stem cells, similar to those found in bone marrow, and these can be used to treat many different cancers, immune deficiencies and genetic disorders. For the transplant to be a success, stem cells taken from the cord blood must match the patient's tissue type as closely as possible.

1.3. The recent report from the UK Stem Cell Strategic Forum sets out a strategy to save an additional 200 lives year by increasing the number of umbilical cord blood units banked in the UK. NHSBT currently banks ~2300 units/annum and will continue to do so until an optimal bank size of 30 000 has been reached by 2020. After which banking will continue at a reduced rate.

1.4. The NHS CBB has been performing plasma and red cell depletion of cord blood prior to cryopreservation since 1997 and has utilised a fully automated centrifugation based processing platform since 2003 and requires a functionally closed, sterile, automated separation system.

II.2.5) Award criteria

Quality criterion: Technical — Pass/Fail / Weighting: 65

Quality criterion: Quality — Pass/Fail / Weighting: 0

Quality criterion: Delivery performance — Pass/Fail / Weighting: 0

Quality criterion: General — Pass/Fail / Weighting: 0

Quality criterion: Cost / Weighting: 40

Price / Weighting:  65

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.3) Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2017/S 121-244693

Section V: Award of contract

Contract No: NHSBT0982

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

01/04/2018

V.2.2) Information about tenders

Number of tenders received: 2

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Biosafe SA

Eysins

CH

E-mail: info.biosafe@ge.com

NUTS: CH

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 283 470.00  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.4) Procedures for review

VI.4.1) Review body

As per VI.4.2 below

Bristol

UK

VI.4.2) Body responsible for mediation procedures

NHS Blood and Transplant

500 Northway, North Bristol Park

Filton, Bristol

BS34 7QH

UK

VI.4.4) Service from which information about the review procedure may be obtained

As per VI.4.2 above

Bristol

UK

VI.5) Date of dispatch of this notice

05/04/2018

Coding

Commodity categories

ID Title Parent category
33100000 Medical equipments Medical equipments, pharmaceuticals and personal care products

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
marnie.watkins@nhsbt.nhs.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.